Hall Laurie J Trustee Immuno Gen, Inc. Transaction History

Hall Laurie J Trustee

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$4.55 - $6.31 $1,114 - $1,545	-245 Reduced 36.3%	430 $2,000
Q3 2022 Oct 11, 2022	SELL	$4.48 - $6.47 $1,366 - $1,973	-305 Reduced 31.12%	675 $3,000
Q4 2021 Jan 05, 2022	BUY	$4.75 - $7.5 $1,615 - $2,550	340 Added 53.13%	980 $7,000
Q3 2021 Oct 04, 2021	SELL	$5.02 - $6.59 $2,007 - $2,636	-400 Reduced 38.46%	640 $4,000
Q3 2020 Oct 09, 2020	BUY	$3.45 - $4.89 $1,138 - $1,613	330 Added 46.48%	1,040 $4,000
Q4 2019 Feb 12, 2020	BUY	$2.25 - $5.8 $270 - $696	120 Added 20.34%	710 $4,000
Q1 2019 May 02, 2019	BUY	$2.41 - $5.91 $650 - $1,595	270 Added 84.38%	590 $2,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $236 - $582	-60 Reduced 15.79%	320 $2,000
Q4 2017 Jan 30, 2018	SELL	$5.07 - $7.92 $912 - $1,425	-180 Reduced 32.14%	380 $2,000
Q2 2017 Aug 22, 2017	BUY	N/A	560	560 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.